News
EVAX
3.090
-1.59%
-0.050
Weekly Report: what happened at EVAX last week (0615-0619)?
Weekly Report · 5d ago
Weekly Report: what happened at EVAX last week (0608-0612)?
Weekly Report · 06/15 10:23
Evaxion Wins 2026 Prix Galien UK Award for AI-Immunology Digital Health Platform
TipRanks · 06/12 10:31
Evaxion receives Prix Galien UK Award for Best digital health solution
Barchart · 06/12 02:00
Evaxion Unveils Promising Preclinical Data for AI-Designed AML Vaccine EVX-04
TipRanks · 06/11 10:28
Evaxion Unveils New EVX-04 Data In AML Study; Stock Up
NASDAQ · 06/11 08:00
Evaxion Says AI-Immunology-Developed EVX-04 Shows Immune Activation And Targeted Cell-Killing In Preclinical Acute Myeloid Leukemia Data
Benzinga · 06/11 06:58
Evaxion reports new preclinical data for EVX-04 AML therapeutic vaccine ahead of EHA 2026 poster
PUBT · 06/11 06:00
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
Barchart · 06/11 01:00
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation?
Seeking Alpha · 06/10 19:19
Weekly Report: what happened at EVAX last week (0601-0605)?
Weekly Report · 06/08 10:19
Weekly Report: what happened at EVAX last week (0525-0529)?
Weekly Report · 06/01 10:24
Weekly Report: what happened at EVAX last week (0518-0522)?
Weekly Report · 05/25 10:27
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 05/19 21:06
Weekly Report: what happened at EVAX last week (0511-0515)?
Weekly Report · 05/18 10:27
Evaxion to Showcase New EVX-04 AML Vaccine Data at EHA 2026
TipRanks · 05/12 14:25
Evaxion To Present Preclinical EVX-04 AML Vaccine Data At EHA 2026, Advancing Toward Planned Clinical Trial Submission In 2H 2026
Benzinga · 05/12 13:34
Evaxion plans EVX-04 AML vaccine clinical trial application in H2 2026
PUBT · 05/12 13:31
Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress
Barchart · 05/12 08:30
Evaxion Biotech (EVAX) Gets a Buy from H.C. Wainwright
TipRanks · 05/11 10:38
More
Webull provides a variety of real-time EVAX stock news. You can receive the latest news about Evaxion AS through multiple platforms. This information may help you make smarter investment decisions.
About EVAX
Evaxion A/S, formerly known as Evaxion Biotech A/S, is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.